Suppr超能文献

降钙素原作为脓毒症的诊断标志物:系统评价和荟萃分析。

Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis.

机构信息

Department of Medical Statistics, Computer Sciences and Documentation, Centre for Sepsis Control and Care, Jena University Hospital, Jena, Germany.

出版信息

Lancet Infect Dis. 2013 May;13(5):426-35. doi: 10.1016/S1473-3099(12)70323-7. Epub 2013 Feb 1.

Abstract

BACKGROUND

Procalcitonin is a promising marker for identification of bacterial infections. We assessed the accuracy and clinical value of procalcitonin for diagnosis of sepsis in critically ill patients.

METHODS

We searched Medline, Embase, ISI Web of Knowledge, the Cochrane Library, Scopus, BioMed Central, and Science Direct, from inception to Feb 21, 2012, and reference lists of identified primary studies. We included articles written in English, German, or French that investigated procalcitonin for differentiation of septic patients--those with sepsis, severe sepsis, or septic shock--from those with a systemic inflammatory response syndrome of non-infectious origin. Studies of healthy people, patients without probable infection, and children younger than 28 days were excluded. Two independent investigators extracted patient and study characteristics; discrepancies were resolved by consensus. We calculated individual and pooled sensitivities and specificities. We used I(2) to test heterogeneity and investigated the source of heterogeneity by metaregression.

FINDINGS

Our search returned 3487 reports, of which 30 fulfilled the inclusion criteria, accounting for 3244 patients. Bivariate analysis yielded a mean sensitivity of 0 · 77 (95% CI 0 · 72-0 · 81) and specificity of 0 · 79 (95% CI 0 · 74-0 · 84). The area under the receiver operating characteristic curve was 0 · 85 (95% CI 0 · 81-0 · 88). The studies had substantial heterogeneity (I(2)=96%, 95% CI 94-99). None of the subgroups investigated--population, admission category, assay used, severity of disease, and description and masking of the reference standard--could account for the heterogeneity.

INTERPRETATION

Procalcitonin is a helpful biomarker for early diagnosis of sepsis in critically ill patients. Nevertheless, the results of the test must be interpreted carefully in the context of medical history, physical examination, and microbiological assessment.

FUNDING

Ministry of Education and Research, the Deutsche Forschungsgemeinschaft, Thuringian Ministry for Education, Science and Culture, the Thuringian Foundation for Technology, Innovation and Research, and the German Sepsis Society.

摘要

背景

降钙素原是一种很有前途的标志物,可用于识别细菌感染。我们评估了降钙素原在诊断危重病患者脓毒症中的准确性和临床价值。

方法

我们检索了 Medline、Embase、ISI Web of Knowledge、Cochrane 图书馆、Scopus、BioMed Central 和 Science Direct,检索时间截至 2012 年 2 月 21 日,并查阅了已确定的原始研究的参考文献列表。我们纳入了以英文、德文或法文发表的研究,这些研究均探讨了降钙素原在鉴别脓毒症患者(败血症、严重败血症或败血症性休克患者)与非感染性全身炎症反应综合征患者中的作用。我们排除了健康人群、无可能感染患者以及 28 天以下的儿童患者的研究。两名独立的研究者提取了患者和研究特征;意见不一致时,通过协商解决。我们计算了个体和汇总的敏感性和特异性。我们使用 I(2)检验异质性,并通过元回归分析探究异质性的来源。

结果

我们的检索共返回 3487 份报告,其中 30 份符合纳入标准,共纳入 3244 例患者。双变量分析得出的平均敏感性为 0.77(95%CI 0.72-0.81),特异性为 0.79(95%CI 0.74-0.84)。受试者工作特征曲线下面积为 0.85(95%CI 0.81-0.88)。研究存在很大的异质性(I(2)=96%,95%CI 94-99)。我们研究的任何亚组——人群、入院类别、使用的检测方法、疾病严重程度以及参考标准的描述和设盲——都无法解释这种异质性。

解释

降钙素原是诊断危重病患者脓毒症的一种有用的生物标志物。然而,必须根据病史、体格检查和微生物学评估来仔细解读检测结果。

资助

德国联邦教育与研究部、德国研究基金会、图林根州教育、科学和文化部、图林根州技术、创新与研究基金会和德国脓毒症学会。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验